CCO Slideset

EGFR-Targeted Antibodies: Clinical Applications, Treatment Challenges, and Ongoing Scientific Research


Source: Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment


David Cunningham, MD, FRCP discusses the rationale for targeting the EGFR with monoclonal antibodies and gives an update on their use in gastrointestinal cancers as monotherapy and in combination with chemotherapies.


Format: UNKNOWN | File size: 6.38 MB | Date posted: 6/12/2008


*You must be logged into the clinicaloptions.com site to view or save the slides.

Users are encouraged to use these slides in their own presentations, but we ask that content and attribution not be changed. Users are asked to honor this intent. These slides may not be published or posted online without permission from Clincal Care Options.